188 related articles for article (PubMed ID: 15076246)
1. Seroepidemiology of HTLV-I/II in Argentina: an overview.
Gastaldello R; Hall WW; Gallego S
J Acquir Immune Defic Syndr; 2004 Mar; 35(3):301-8. PubMed ID: 15076246
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: a South American health concern.
Biglione MM; Astarloa L; Salomón HE;
AIDS Res Hum Retroviruses; 2005 Jan; 21(1):1-4. PubMed ID: 15665638
[TBL] [Abstract][Full Text] [Related]
3. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
4. [Detection of Human T lymphotropic virus 1 (HTLV-1) Cosmopolitan subtype Transcontinental subgroup (Aa) and HTLV-2 subtype b in blood donors of Corrientes].
Borda MA; Svibel GR; Biglione MM; Berini CA
Rev Argent Microbiol; 2019; 51(4):307-315. PubMed ID: 30935721
[TBL] [Abstract][Full Text] [Related]
5. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
Berini CA; Pando MA; Bautista CT; Eirin ME; Martinez-Peralta L; Weissenbacher M; Avila MM; Biglione MM
J Med Virol; 2007 Dec; 79(12):1914-20. PubMed ID: 17935172
[TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of HTLV-1 and HTLV-2 Infection in Neyshabur City, North-Eastern Iran, during 2010-2014.
Salehi M; Shokouhi Mostafavi SK; Ghasemian A; Gholami M; Kazemi-Vardanjani A; Rahimi MK
Iran Biomed J; 2017 Jan; 21(1):57-60. PubMed ID: 26899860
[TBL] [Abstract][Full Text] [Related]
8. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
9. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
Jõgeda EL; Avi R; Pauskar M; Kallas E; Karki T; Des Jarlais D; Uusküla A; Lutsar I; Huik K
Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.
Morais MPE; Gato CM; Maciel LA; Lalwani P; Costa CA; Lalwani JDB
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e80. PubMed ID: 29267588
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV-1, HIV-2 and HTLV antibody, in Fortaleza, Ceara, Brazil, 1993-1994.
Broutet N; de Queiroz Sousa A; Basilio FP; Sá HL; Simon F; Dabis F
Int J STD AIDS; 1996; 7(5):365-9. PubMed ID: 8894828
[TBL] [Abstract][Full Text] [Related]
12. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
13. HTLV type I and HTLV type II infection among Indians and natives from Argentina.
Bouzas MB; Zapiola I; Quiruelas S; Gorvein D; Panzita A; Rey J; Carnese FP; Corral R; Perez C; Zala C
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1567-71. PubMed ID: 7888211
[TBL] [Abstract][Full Text] [Related]
14. Stable human T-cell lymphotropic virus type 1 (HTLV-1) subtype a/subgroup a endemicity in Amerindians from Northwest Argentina: a health problem to be resolved.
Eirin ME; Berini CA; Jones LR; Dilernia DA; Puca AA; Biglione MM
J Med Virol; 2010 Dec; 82(12):2116-22. PubMed ID: 20981802
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of HTLV-I/HTLV-II in blood donors in Buenos Aires (Argentina).
Gutfraind Z; Blejer JL; Saguier MC; Gomez Carretero ML; Pirola DA; Carreras Vescio LA
Vox Sang; 1994; 67(4):408-9. PubMed ID: 7701816
[No Abstract] [Full Text] [Related]
17. HTLV-I/II prevalence in different geographic locations.
Vrielink H; Reesink HW
Transfus Med Rev; 2004 Jan; 18(1):46-57. PubMed ID: 14689377
[TBL] [Abstract][Full Text] [Related]
18. Presence of HTLV-I and HTLV-II infection in Honduras.
Segurado A; Granade T; Parekh B; Nunez CA; Meza R; Amador L; Terrell S; George JR; Lal RB
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):308. PubMed ID: 9402080
[No Abstract] [Full Text] [Related]
19. Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil.
Barcellos NT; Fuchs SC; Mondini LG; Murphy EL
Sex Transm Dis; 2006 May; 33(5):302-6. PubMed ID: 16505751
[TBL] [Abstract][Full Text] [Related]
20. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
